{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:40:39Z","timestamp":1793083239309,"version":"4.5.0"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease in which immune dysregulation plays a central role. As the life expectancy of people with MS (pwMS) increases, understanding how aging affects their immune system\u2014collectively referred to as immunosenescence\u2014has become crucial. In this study, we characterized immunosenescence in pwMS by analyzing age-related changes in the immune system. To fulfill this, blood samples were collected from pwMS and healthy controls (HCs) of independent cohorts: i) immune cell populations were assessed in PBMCs (n= 110), ii) thymic involution and telomere attrition were measured in DNA samples (n=150), and iii) inflammatory and neurodegeneration markers were evaluated in plasma (n=146).Our results revealed distinct age-associated alterations in immune cell subsets between pwMS and HCs, including B and NK cells. Notably, pwMS showed an age-related increase in CD28\u2013CD57+ and CD28+CD57+ cells in CD4+ and CD8+ T cells. Thymic involution was reported with age in both groups and, importantly, we found a more pronounced thymic involution in younger pwMS. A positive correlation was found between age and the levels of IL-6, TNF-\u03b1, and CRP in pwMS, results consistent with the inflammaging phenomenon. Similarly, NFL levels were elevated in pwMS and correlated positively with age in both groups., Remarkably, we found a positive correlation between NFL levels and IL-6, and between NFL levels and TNF-\u03b1 only in pwMS. Telomere shortening occurred with age in both groups, without significant differences. Notably, our study provides an integrative and multi-biomarker characterization of immune aging process in pwMS, revealing new insights into this complex relationship. These findings highlight specific age-related immune alterations in MS and underscore the importance of incorporating age and immunosenescence monitoring into MS clinical management and therapeutic strategies.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1663526","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:08:57Z","timestamp":1759406937000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Aging-dependent immunological changes in multiple sclerosis"],"prefix":"10.3389","volume":"16","author":[{"given":"Andrea","family":"Iribarren-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Martins-Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadon K","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Castillo-Trivi\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Prada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilda A","family":"Pickett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainhoa","family":"Alberro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Otaegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-052920-040318","article-title":"The immune response in multiple sclerosis","volume":"17","author":"Rodr\u00edguez Mur\u00faa","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat Rev Dis Prim"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2012.10.021","article-title":"Environmental factors and their regulation of immunity in multiple sclerosis","volume":"324","author":"Koch","year":"2013","journal-title":"J Neurol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70305-9","article-title":"Role of the innate and adaptive immune responses in the course of multiple sclerosis","volume":"14","author":"Hemmer","year":"2015","journal-title":"Lancet Neurol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ene.12798","article-title":"A basic overview of multiple sclerosis immunopathology","volume":"22","author":"Grigoriadis","year":"2015","journal-title":"Eur J Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2004.11.001","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Bar-Or","year":"2005","journal-title":"Neurol Clin"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp070","article-title":"The relation between inflammation and neurodegeneration in multiple sclerosis brains","volume":"132","author":"Frischer","year":"2009","journal-title":"Brain"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41467-017-01571-8","article-title":"Transcriptional signature of human pro-inflammatory TH17 cells identifies reduced IL10 gene expression in multiple sclerosis","volume":"8","author":"Hu","year":"2017","journal-title":"Nat Commun"},{"key":"B10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/ana.21652","article-title":"T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta","volume":"65","author":"Durelli","year":"2009","journal-title":"Ann Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2567.2007.02690.x","article-title":"Compromised CD4+ CD25high regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level","volume":"123","author":"Venken","year":"2008","journal-title":"Immunology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2006.03271.x","article-title":"Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients","volume":"147","author":"Feger","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(95)00115-9","article-title":"Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controls","volume":"62","author":"Munschauer","year":"1995","journal-title":"J Neuroimmunol"},{"key":"B14","first-page":"1","volume-title":"Atlas of MS","year":"2020"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1177\/1352458506070775","article-title":"MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis","volume":"12","author":"Butzkueven","year":"2006","journal-title":"Mult Scler"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102893","article-title":"Immunosenescence in multiple sclerosis: the identification of new therapeutic targets","volume":"20","author":"Dema","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/4.4.195","article-title":"The immunologic theory of aging","volume":"4","author":"Walford","year":"1964","journal-title":"Gerontologist"},{"key":"B18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.arr.2017.10.005","article-title":"The influence and impact of ageing and immunosenescence (ISC) on adaptive immunity during multiple sclerosis (MS) and the animal counterpart experimental autoimmune encephalomyelitis (EAE)","volume":"41","author":"Bolton","year":"2018","journal-title":"Ageing Res Rev"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01993","article-title":"Human T cell differentiation negatively regulates telomerase expression resulting in reduced activation-induced proliferation and survival","volume":"10","author":"Patrick","year":"2019","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e12859","DOI":"10.1111\/acel.12859","article-title":"Telomere length and telomerase activity in T cells are biomarkers of high-performing centenarians","volume":"18","author":"Tedone","year":"2019","journal-title":"Aging Cell"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02247","article-title":"Immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention","volume":"10","author":"Aiello","year":"2019","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cytogfr.2021.01.006","article-title":"Hallmarks of aging and immunosenescence: Connecting the dots","volume":"59","author":"Rodrigues","year":"2021","journal-title":"Cytokine Growth Factor Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrleng.2020.05.023","article-title":"Immunosenescence: the role of age in multiple sclerosis","volume":"38","author":"Ostolaza Ib\u00e1\u00f1ez","year":"2022","journal-title":"Neurologia"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1361.066","article-title":"Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients","volume":"1051","author":"Thewissen","year":"2005","journal-title":"Ann New York Acad Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0129217","article-title":"Thymic atrophy and apoptosis of CD4+CD8+ Thymocytes in the cuprizone model of multiple sclerosis","volume":"10","author":"Solti","year":"2015","journal-title":"PloS One"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-016-0471-2","article-title":"HIV and decreased risk of multiple sclerosis: role of low CD4+ lymphocyte count and male prevalence","volume":"23","author":"Koudriavtseva","year":"2017","journal-title":"J Neurovirol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr268","article-title":"Central nervous system recruitment of effector memory CD8+ T lymphocytes during neuroinflammation is dependent on \u03b14 integrin","volume":"134","author":"Ifergan","year":"2011","journal-title":"Brain"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2012.06.003","article-title":"Pathogenic features of CD4+CD28\u2013 T cells in immune disorders","volume":"18","author":"Broux","year":"2012","journal-title":"Trends Mol Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00207454.2022.2098737","article-title":"Telomere length and multiple sclerosis: a Mendelian randomization study","volume":"134","author":"Ma","year":"2022","journal-title":"Int J Neurosci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2010.12.007","article-title":"Reduced thymic output and peripheral na\u00efve CD4 T-cell alterations in primary progressive multiple sclerosis (PPMS)","volume":"233","author":"Haegert","year":"2011","journal-title":"J Neuroimmunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502448","article-title":"Age-associated B cells with proinflammatory characteristics are expanded in a proportion of multiple sclerosis patients","volume":"197","author":"Claes","year":"2016","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201948362","article-title":"CD28 and CD57 define four populations with distinct phenotypic properties within human CD8(+) T cells","volume":"50","author":"Pangrazzi","year":"2020","journal-title":"Eur J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0042412","article-title":"Predicting human age with bloodstains by sjTREC quantification","volume":"7","author":"Ou","year":"2012","journal-title":"PloS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1038\/s41467-019-10180-6","article-title":"The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT)","volume":"10","author":"Lu","year":"2019","journal-title":"Nat Commun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00316","article-title":"The effect of age on thymic function","volume":"4","author":"Palmer","year":"2013","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00414-010-0528-3","article-title":"Detection and quantification of the age-related sjTREC decline in human peripheral blood","volume":"125","author":"Ou","year":"2011","journal-title":"Int J Legal Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.18632\/aging.101220","article-title":"Progressive changes in non-coding RNA profile in leucocytes with age","volume":"9","author":"Mu\u00f1oz-Culla","year":"2017","journal-title":"Aging (Albany NY)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2015.09.003","article-title":"Age gene expression and coexpression progressive signatures in peripheral blood leukocytes","volume":"72","author":"Irizar","year":"2015","journal-title":"Exp Gerontol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging. An evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1159\/000497375","article-title":"Human inflammaging","volume":"65","author":"F\u00fcl\u00f6p","year":"2019","journal-title":"Gerontology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/345458a0","article-title":"Telomeres shorten during ageing of human fibroblasts","volume":"345","author":"Harley","year":"1990","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: An expanding universe","volume":"186","author":"L\u00f3pez-Ot\u00edn","year":"2023","journal-title":"Cell"},{"key":"B44","volume-title":"Datos oficiales de Esclerosis M\u00faltiple en Espa\u00f1a","year":"2021"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1159\/000328005","article-title":"Immunosenescence of human natural killer cells","volume":"3","author":"Gayoso","year":"2011","journal-title":"J Innate Immun"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2023.1234572","article-title":"Immunosenescence and multiple sclerosis: inflammaging for prognosis and therapeutic consideration","volume":"4","author":"Thakolwiboon","year":"2023","journal-title":"Front Aging"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00718-z","article-title":"The immunology of multiple sclerosis","volume":"22","author":"Attfield","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-016-1803-z","article-title":"CD57 in human natural killer cells and T-lymphocytes","volume":"65","author":"Kared","year":"2016","journal-title":"Cancer Immunol Immunother"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-2103","article-title":"Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells","volume":"101","author":"Brenchley","year":"2003","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-7-66","article-title":"Accumulation of neutral lipids in peripheral blood mononuclear cells as a distinctive trait of Alzheimer patients and asymptomatic subjects at risk of disease","volume":"7","author":"Pani","year":"2009","journal-title":"BMC Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-023-00810-9","article-title":"Age-related changes in energy metabolism in peripheral mononuclear blood cells (PBMCs) and the brains of cognitively healthy seniors","volume":"46","author":"Silaidos","year":"2024","journal-title":"GeroScience"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1440-1711.2002.01057.x","article-title":"CD8+CD28- T cells: certainties and uncertainties of a prevalent human T-cell subset","volume":"80","author":"Arosa","year":"2002","journal-title":"Immunol Cell Biol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2005.00256.x","article-title":"CD28 extinction in human T cells: altered functions and the program of T-cell senescence","volume":"205","author":"Vallejo","year":"2005","journal-title":"Immunol Rev"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104179","article-title":"Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age","volume":"82","author":"Zuroff","year":"2022","journal-title":"EBioMedicine"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.2.2.249-252.1995","article-title":"Alterations in levels of CD28-\/CD8+ suppressor cell precursor and CD45RO+\/CD4+ memory T lymphocytes in the peripheral blood of multiple sclerosis patients","volume":"2","author":"Crucian","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e200075","DOI":"10.1212\/NXI.0000000000200075","article-title":"Increased percentage of CD8+CD28\u2013 regulatory T cells with fingolimod therapy in multiple sclerosis","volume":"10","author":"Houston","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14191","article-title":"Influence of age at disease onset on future relapses and disability progression in patients with multiple sclerosis on immunomodulatory treatment","volume":"27","author":"von Wyl","year":"2020","journal-title":"Eur J Neurol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.archger.2015.08.007","article-title":"Aging-associated subpopulations of human CD8+ T-lymphocytes identified by their CD28 and CD57 phenotypes","volume":"61","author":"Onyema","year":"2015","journal-title":"Arch Gerontol Geriatr"},{"key":"B60","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1046\/j.1365-2249.1998.00551.x","article-title":"Progressive decrease of CD8high+ CD28+ CD57- cells with ageing","volume":"112","author":"Merino","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102517","article-title":"T cells and immune functions of plasma extracellular vesicles are differentially modulated from adults to centenarians","volume":"11","author":"Alberro","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2023.114579","article-title":"Altered T cell development in an animal model of multiple sclerosis","volume":"371","author":"Jiang","year":"2024","journal-title":"Exp Neurol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jneuroim.2010.02.005","article-title":"Thymic involution and proliferative T-cell responses in multiple sclerosis","volume":"221","author":"Duszczyszyn","year":"2010","journal-title":"J Neuroimmunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2007.10.027","article-title":"Thymic output and peripheral T lymphocyte subsets in relapsing\u2013remitting multiple sclerosis patients treated or not by IFN-beta","volume":"193","author":"Puissant-Lubrano","year":"2008","journal-title":"J Neuroimmunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.51.1.245","article-title":"Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty","volume":"51","author":"Ershler","year":"2000","journal-title":"Annu Rev Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12979-016-0076-x","article-title":"Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study","volume":"13","author":"Puzianowska-Ku\u017anicka","year":"2016","journal-title":"Immun Ageing"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/s0022-510x(96)00283-3","article-title":"IL-6 detection in multiple sclerosis brain","volume":"146","author":"Maimone","year":"1997","journal-title":"J Neurol Sci"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(95)00155-7","article-title":"Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis","volume":"64","author":"Navikas","year":"1996","journal-title":"J Neuroimmunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.00120","article-title":"IL-6 in the cerebrospinal fluid signals disease activity in multiple sclerosis","volume":"14","author":"Stampanoni Bassi","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(91)90020-8","article-title":"Interleukin-6 is elevated in plasma in multiple sclerosis","volume":"31","author":"Frei","year":"1991","journal-title":"J Neuroimmunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s41232-021-00184-5","article-title":"Interleukin-6: evolving role in the management of neuropathic pain in neuroimmunological disorders","volume":"41","author":"Serizawa","year":"2021","journal-title":"Inflammation Regener"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108153250704","article-title":"Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis","volume":"325","author":"Sharief","year":"1991","journal-title":"N Engl J Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.3390\/cells9102290","article-title":"Re-examining the role of TNF in MS pathogenesis and therapy","volume":"9","author":"Fresegna","year":"2020","journal-title":"Cells"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-015-0357-7","article-title":"Inflammatory Markers Change with Age, but do not Fall Beyond Reported Normal Ranges","volume":"64","author":"Wyczalkowska-Tomasik","year":"2016","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B76","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.neuropharm.2014.10.020","article-title":"The therapeutic potential of interleukin-10 in neuroimmune diseases","volume":"96","author":"Kwilasz","year":"2015","journal-title":"Neuropharmacology"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518763094","article-title":"Cytokine signaling in multiple sclerosis: Lost in translation","volume":"24","author":"G\u00f6bel","year":"2018","journal-title":"Mult Scler J"},{"key":"B78","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41392-023-01451-2","article-title":"Immunosenescence: molecular mechanisms and diseases","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B79","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.smim.2018.09.003","article-title":"The integration of inflammaging in age-related diseases","volume":"40","author":"Fulop","year":"2018","journal-title":"Semin Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.1999.00546.x","article-title":"Multiple sclerosis: levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-\u03b2-1b treatment","volume":"49","author":"\u00d6zenci","year":"1999","journal-title":"Scand J Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-017-0006-x","article-title":"The twilight of immunity: emerging concepts in aging of the immune system","volume":"19","author":"Nikolich-\u017dugich","year":"2018","journal-title":"Nat Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-023-02552-6","article-title":"IL-10-providing B cells govern pro-inflammatory activity of macrophages and microglia in CNS autoimmunity","volume":"145","author":"Geladaris","year":"2023","journal-title":"Acta Neuropathol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3390\/biom10071017","article-title":"The regulatory role of IL-10 in neurodegenerative diseases","volume":"10","author":"Porro","year":"2020","journal-title":"Biomolecules"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200607","article-title":"The T cell response to IL-10 alters cellular dynamics and paradoxically promotes central nervous system autoimmunity","volume":"189","author":"Liu","year":"2012","journal-title":"J Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110565","article-title":"CD4(+) T-cell-derived IL-10 promotes CNS inflammation in mice by sustaining effector T cell survival","volume":"38","author":"Yogev","year":"2022","journal-title":"Cell Rep"},{"key":"B86","doi-asserted-by":"publisher","first-page":"20552173221139770","DOI":"10.1177\/20552173221139768","article-title":"Systemic inflammation and risk of multiple sclerosis \u2013 A presymptomatic case-control study","volume":"8","author":"Grut","year":"2022","journal-title":"Mult Scler J \u2013 Exp Transl Clin"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/46.7.934","article-title":"Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population","volume":"46","author":"Hutchinson","year":"2000","journal-title":"Clin Chem"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/s40279-024-02152-8","article-title":"Does lifelong exercise counteract low-grade inflammation associated with aging? A systematic review and meta-analysis","volume":"55","author":"P\u00e9rez-Castillo","year":"2025","journal-title":"Sports Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00098","article-title":"Effect of aerobic exercise on inflammatory markers in healthy middle-aged and older adults: A systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Zheng","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2018.07.021","article-title":"Effect of resistance training on inflammatory markers of older adults: A meta-analysis","volume":"111","author":"Sardeli","year":"2018","journal-title":"Exp Gerontol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab241","article-title":"The potential of serum neurofilament as biomarker for multiple sclerosis","volume":"144","author":"Bittner","year":"2021","journal-title":"Brain"},{"key":"B92","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12974-024-03036-4","article-title":"Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes","volume":"21","author":"Kodosaki","year":"2024","journal-title":"J Neuroinflamm"},{"key":"B93","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41467-020-14612-6","article-title":"Serum neurofilament light levels in normal aging and their association with morphologic brain changes","volume":"11","author":"Khalil","year":"2020","journal-title":"Nat Commun"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.1.432","article-title":"Thymic export function and T cell homeostasis in patients with relapsing remitting multiple sclerosis","volume":"171","author":"Hug","year":"2003","journal-title":"J Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103731","article-title":"Genetically predicted telomere length and multiple sclerosis","volume":"60","author":"Shu","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577187","article-title":"Association between shorter leukocyte telomeres and multiple sclerosis","volume":"341","author":"Habib","year":"2020","journal-title":"J Neuroimmunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2021.0106","article-title":"Systematic review of studies on telomere length in patients with multiple sclerosis","volume":"12","author":"B\u00fchring","year":"2021","journal-title":"Aging Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1663526\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:08:58Z","timestamp":1759406938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1663526\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":97,"alternative-id":["10.3389\/fimmu.2025.1663526"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1663526","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"article-number":"1663526"}}